The growth strategies of a global pharmaceutical company: a case study of Aspen Pharmacare Holdings Limited
Journal: Problems and Perspectives in Management (Vol.15, No. 1)Publication Date: 2017-05-11
Authors : Victoria Margaret Hodgon; Muhammad Ehsanul Hoque;
Page : 248-259
Keywords : challenges; global expansion; growth strategy; leadership; pharmaceutical company; South Africa;
Abstract
Given the rapid and sustained growth of Aspen over the past decade, the main aim of this study is to identify and analyze the growth strategies, adopted by Aspen over the period from 2004 to 2014. The research method used was a descriptive study through a single case study of Aspen by analyzing secondary data in the form of publicly available company reports and presentations, as well as financial results, issued between 2004 and 2014. The study finds that, guided by strategic and visionary leadership, Aspen adopted a number of growth strategies including (i) organic growth, as a key factor in creating incremental value for Aspen and its stakeholders, (ii) inorganic growth, in the form of carefully planned and well executed acquisitions, aligned to the Group strategy, (iii) extending territorial coverage through global expansion, particularly into emerging pharmaceutical countries, and (iv) ongoing investment in production capabilities as a means of achieving a strategic advantage. Despite the challenges of intense competition, restrictive legislation, pressure on medicine prices, currency volatility and market specific risks, Aspen has delivered double-digit earnings growth to its shareholders for 16 consecutive years.
Other Latest Articles
- ASSESSMENT OF APPLICATION OF 5S PRACTICES IN CERAMIC INDUSTRY
- SUPPORTING AUTONOMOUS VEHICLES BY CREATING HD MAPS
- CHIP BREAKING PHENOMENON DURING CUTTING STEEL AND POLYMER MATERIALS
- The nature of China’s role in development of Africa: the case of Zimbabwe
- WORK SAFETY IN PRODUCTION PROCESSES LOCATED IN POLAND
Last modified: 2018-03-12 22:03:56